What is your background with OPT? Where do you fit on the P3 COAST success probability scale; 50, 60, 70, 80, or 90%?
I agree that the next six months will change everything; however, the next three months; and the readout; will determine whether the game is won or lost. If COAST fails, it would invalidate the science; and SHORE would be in serious doubt as well unless there was a really good explaination.
Obviously, I’m a big holder; so after research I have formed the belief ( strong beliefs loosly held) that both COAST and SHORE are extremely likely (80+%) to achieve clinical significance; even in subgroups.
Obviously with that dark side of a remote possibility of failure IMHO the only real question for the P3 science is; how many letters; 2,3,4,5,6+
- Forums
- ASX - By Stock
- OPT
- Opthea (OPT) - The BREAKTRHOUGH in Vision Treatment IMMINENT
OPT
opthea limited
Add to My Watchlist
0.00%
!
60.0¢

Opthea (OPT) - The BREAKTRHOUGH in Vision Treatment IMMINENT, page-14
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
60.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $738.7M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
OPT (ASX) Chart |
Day chart unavailable